ALK and inflammatory myofibroblastic tumor: This study demonstrated the possible role of <i>EML4</i>-<i>ALK</i>v3a/b in the malignant progression of IMT and proposed certain therapeutic effects of <i>ALK</i> inhibitors on multiple metastatic IMTs.